Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Scrip Awards
Partnered Content
Scrip Asia 100
Report Store
Ask The Analyst
PItCH
PDF Library
RSS Feeds
Subscribe
Advertise
UsernamePublicRestriction
Tags:
Consumer OTC Drugs

Excedrin Migraine Full Migraine Indication Approved By FDA

This article was originally published in The Tan Sheet

  • News
  • The Tan Sheet

Executive Summary

Bristol-Myers Squibb's Excedrin Migraine indication for full migraine syndrome was approved by FDA Oct. 7. The new labeling simply bears the indication "Treats migraine."

You may also be interested in...



Advil Migraine Liqui-Gels Join Growing Category, Stress Distinctiveness

Upcoming marketing efforts accompanying the introduction of Whitehall-Robins' Advil Migraine Liqui-Gels likely will attempt to differentiate the product from its migraine-specific competitors by emphasizing the analgesic's speedy delivery form.

Advil Migraine Liqui-Gels Join Growing Category, Stress Distinctiveness

Upcoming marketing efforts accompanying the introduction of Whitehall-Robins' Advil Migraine Liqui-Gels likely will attempt to differentiate the product from its migraine-specific competitors by emphasizing the analgesic's speedy delivery form.

Advil Migraine Liqui-Gels Join Growing Category, Stress Distinctiveness

Upcoming marketing efforts accompanying the introduction of Whitehall-Robins' Advil Migraine Liqui-Gels likely will attempt to differentiate the product from its migraine-specific competitors by emphasizing the analgesic's speedy delivery form.
Table

View full table

Related Content

Pink Sheet Pink Sheet Pink Sheet Pink Sheet Pink Sheet Pink Sheet Pink Sheet

Topics

Tags:
Consumer OTC Drugs
UsernamePublicRestriction

Register

PS090407

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By